Results 11 to 20 of about 32,196 (304)

Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases

BMC Ophthalmology, 2022
Background Acquired nasolacrimal duct obstruction is a blockage of the lacrimal outflow system usually caused by local nonspecific inflammation of the lacrimal sac and the nasolacrimal duct.
Almantas Makselis, Donatas Petroska, Aiste Kadziauskiene, Ruta Jaruseviciene, Andrius Ruzgys, Andrius Cimbalas, Justinas Besusparis, Rimvydas S. Asoklis   +7 more
doaj   +2 more sources

Changes in the meibomian glands in postmenopausal women with primary acquired nasolacrimal duct obstruction: a prospective study

BMC Ophthalmology, 2023
Background Primary acquired nasolacrimal duct obstruction (PANDO) is frequently encountered in perimenopausal women, causing tear flow stagnation and resulting in a variety of ocular discomfort symptoms.
Haili Jin, Hong Zhang
doaj   +2 more sources

Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review

Diseases, 2018
Congenital nasolacrimal duct obstruction (CNLDO) is a common condition causing excessive tearing or mucoid discharge from the eyes, due to blockage of the nasolacrimal duct system.
Aldo Vagge, Lorenzo Ferro Desideri, Paolo Nucci, Massimiliano Serafino, Giuseppe Giannaccare, Andrea Lembo, Carlo Enrico Traverso   +6 more
doaj   +2 more sources

Success rates of probing for congenital nasolacrimal duct obstruction at various ages

BMC Ophthalmology, 2020
Background Although nasolacrimal duct probing is the standard treatment for congenital nasolacrimal duct obstruction (CNLDO) among children, the optimal timing of this procedure has been a topic of debate. The aim of the study was to analyze the clinical
Marta Świerczyńska, Ewelina Tobiczyk, Piotr Rodak, Dorota Barchanowska, Erita Filipek   +4 more
doaj   +2 more sources

Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction [PDF]

Cochrane Database of Systematic Reviews, 2017
BACKGROUND: A dacryocystorhinostomy (DCR) procedure aims to restore drainage of tears by bypassing a blockage in the nasolacrimal duct, through the creation of a bony ostium that allows communication between the lacrimal sac and the nasal cavity.
Ajalloueyan, Anijeet, Anijeet, Atkins, Bakri, Balikoglu-Yilmaz, Ben Simon, Boush, Caldwell, Chen, Cokkeser, Cui, Derya, Dolman, Dupuy-Dutemps, Fayers, Glanville, Halle, Hartikainen, Hartikainen, Henson, Hii, Huang, Ibrahim, Javate, Kennedy, Kong, Maini S, Mathew, McDonogh, Metson, Moore, Moras, Muellner, Ng, Pearlman, Qin, Reifler, Roozitalab, Saiju, Seppa, Sham, Smirnov, Stammberger, Tang, Tarbet, Taskin, Toti, Tsirbas, Unlu, Verma, Watts, West, Woog, Yigit, Yuce, Zhou   +56 more
core   +3 more sources

Management of congenital nasolacrimal duct obstruction in down syndrome

Eye, 2022
Daphna Landau Prat, Samuel Tadros, Karen Revere, James A. Katowitz, William R. Katowitz   +4 more
openalex   +3 more sources

Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction in Children

Folia Medica, 2019
Aim: To determine the success rate of initial and repeated probing for congenital nasolacrimal duct obstruction (CNLDO) in children between 2-41 months.
Valcheva Krasina P., Murgova Snezhana V., Krivoshiiska Emilia K.   +2 more
doaj   +2 more sources

Probing and nasolacrimal intubation outcomes in children over 18 Months of age with congenital nasolacrimal duct obstruction. [PDF]

Heliyon
Jafarizadeh A, Manouchehri V, Sobhi N, Mousavi F, Tondro Anamag F.   +4 more
europepmc   +2 more sources

Lacrimal duct obstruction after radioiodine therapy: case report and treatment [PDF]

, 2014
Iodotherapy represents the radioactive iodine therapy. The beta radiation emitted by radioactive iodine are particles that will be stored in the thyroid tissue destroying cancer cells that were left after surgery (thyroidectomy).
Lorena, Silvia Helena Tavares, Silva, João Amaro Ferrari   +1 more
core   +8 more sources

Analysis of surgical interventions outcomes in patients with nasolacrimal duct obliteration due to radioiodine therapy

Офтальмохирургия, 2023
Relevance. Nasolacrimal duct obstruction occurs in 9% of patients after radioiodine therapy for thyroid cancer. The surgical interventions used in this case have not been studied enough; indications for certain operations have not been developed. Purpose.
V.D. Yartsev, E.L. At’kova
doaj   +1 more source